Navigation Links
Ezra Van Gelder Joins Microchip Biotechnologies as Executive Vice President R&D
Date:12/4/2008

DUBLIN, Calif., Dec. 4 /PRNewswire/ -- Microchip Biotechnologies, a private company developing the Apollo next-generation fluidics platform for Life Sciences, announced today that Ezra Van Gelder has joined its team as Executive Vice President of R&D.

Ezra Van Gelder brings Microchip Biotechnologies (MBI) extensive leadership experience in research and development from the life science, medical device and semiconductor equipment industries. Prior to joining MBI, Ezra Van Gelder headed instrument and reagent development for DNA and RNA sample preparation at Arcxis Biosciences. At Molecular Dynamics, Amersham and GE Healthcare, where he was VP of Development for the West Coast, he led development for DNA sequencing and cell analysis. In the semiconductor industry Ezra Van Gelder directed the development of automated optical wafer inspection equipment at KLA Instruments and KLA-Tencor.

"The addition of Ezra Van Gelder, as Executive VP of R&D, further strengthens the world class team at MBI. Ezra brings considerable expertise in developing innovative next generation life science solutions focused on end users and implementing product development processes and ISO 13485," said Dr. Stevan Jovanovich, President and CEO of Microchip Biotechnologies. "Ezra's R&D leadership and experience will accelerate the full integration of sample preparation and analysis on MBI's Apollo platform."

"I have spent much of my career working on separate reagent and analytical instrumentation systems, so I am now relishing the prospect of working with a platform that can genuinely integrate macro and microfluidics to provide much needed, complete sample-to-answer solutions," said Ezra Van Gelder. "The Apollo platform, along with the exceptional group at MBI, will bring new capabilities to life sciences, diagnostics and compact field portable devices for life science applications."

Ezra Van Gelder holds a B.Sc. in Mechanical Engineering from Tel Aviv University, Israel and a M.Sc. in Mechanical Engineering from Santa Clara University, California, USA.

About Microchip Biotechnologies

Microchip Biotechnologies, Inc., also known as MBI, is a privately-held company that is located in Dublin, California. The company is developing the Apollo next-generation fluidics platform for life sciences, applied sciences, and diagnostics markets. The Apollo platform integrates advanced microfluidic sample preparation, and analytical capabilities, to produce sample-to-answer performance for DNA sequencing, biodefense, DNA-based forensics and human identity (HID), and molecular diagnostics applications. The platform incorporates MBI's proprietary BeadStorm(TM) bead-based sample preparation devices and 'Microscale On-Chip Valve' (MOVe(TM)) valves, pumps, and routers on NanoPulse(TM) microchips. More details about the MBI, its technologies and products can be found at: www.microchipbiotech.com.


'/>"/>
SOURCE Microchip Biotechnologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Richard Greco Joins Mediware Board
2. Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program
3. Sean P. McLaughlin Joins Red Cross as Chief of Operations Support
4. Dr. Mahesh Ramachandran Joins Marianjoy Medical Group
5. Nick Childs Joins Grey New York as Director of Content Development
6. Psychemedics Corporation Joins Accenture in Co-Sponsoring Innovative Chief Talent Officer Book
7. David Ward Joins OrthoSynetics(TM) as Western Region Sales Manager
8. NASN Joins Partnership to Fight Chronic Disease
9. AstraZeneca Joins Local Walking Movement
10. Proxy Governance Joins ISS, Glass Lewis and Egan Jones in Recommending Arrow International Shareholders Vote to Approve the $45.50 Per Share Merger With Teleflex
11. Fund Manager Joins Board of GSI Securitization Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... AxoGen, Inc. (NASDAQ: AXGN), a leading ... the fourth quarter and full year ended December 31, 2015 on Monday, February 29, ... webcast for the investment community following the release at 4:30 PM ET. Investors interested ...
(Date:2/10/2016)... Carefree, AZ (PRWEB) , ... February 10, 2016 , ... ... coach in new book , Pioneering book "Better with Age: The Ultimate Guide to ... neuroplasticity can improve memory. The book’s publication date is March 16, 2016. ...
(Date:2/10/2016)... MA (PRWEB) , ... February 10, 2016 , ... ... their revolutionary, biocompatible columns and accessories. These PEEK-lined stainless steel (PLS) columns combine ... provide a solution that ensures the integrity of biological samples while operating at ...
(Date:2/10/2016)... ... February 10, 2016 , ... The recreational use of marijuana has been ... still face a lot of restrictions as to where they can smoke pot. ... use” and that cannabis “may not be consumed openly or publicly.” , Given the ...
(Date:2/10/2016)... ... February 09, 2016 , ... ... Face and Body Specialists are delighted to welcome a new addition to their ... Face and Body Specialists as a nurse practitioner performing cosmetic procedures ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... Corporation ("Unilife" or "Company") (NASDAQ: UNIS ; ASX: UNS), ... its financial results for the second quarter of fiscal 2016 (three ... Financial Results for the Second Quarter of ... Revenue for the second quarter of fiscal 2016 was $4.5 ... Cash receipts from customers for the second quarter of fiscal 2016 ...
(Date:2/9/2016)... February 9, 2016 ... heute den Abschluss eines Kooperationsvertrags mit 10x ... Lösungen in den Bereichen Next-Generation-Sequencing (NGS), Single-Cell-Biology ... ; Frankfurt Prime Standard: QIA) gab heute ... für die Entwicklung und Förderung umfassender Lösungen ...
(Date:2/9/2016)... February 9, 2016 QGEN ... collaboration with 10x Genomics to develop and promote ... and bioinformatics. --> QGEN ; Frankfurt ... 10x Genomics to develop and promote comprehensive solutions ... --> QIAGEN N.V. (NASDAQ: QGEN ...
Breaking Medicine Technology: